| Name | Title | Contact Details |
|---|
Nightstar is a private biopharmaceutical company focused on the development of therapies for retinal dystrophies. The Company’s lead programme is a retinal gene therapy for choroideremia, a rare inherited cause of blindness that affects around 1 in 50,000 people. Gene therapy has the potential to be an effective treatment for choroideremia and a range of other retinal dystrophies. The Company’s lead investors are Syncona LLP and NEA Inc. Syncona is an evergreen investment company, taking an active role in identifying, supporting and developing technologies with the potential to impact significantly the healthcare market of the future. NEA is a global venture capital firm focused on helping entrepreneurs build transformational businesses across multiple stages, sectors and geographies.
A specialty pharmaceutical company focused on the development and commercialization of pharmaceutical technologies to meet important healthcare challenges
Spence Pharmacy & Medical Supl is a River Oaks, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
R2P creates a unique physical therapy experience, offering our blend of performance, return to sport, physical therapy, dry needling and injury prevention.
We specialize in Occupational Medicine. We provide injury care, physicals, drug tests, physical therapy and more. Call today 866-480-1310.